GSK3β: a plausible mechanism of cognitive and hippocampal changes induced by erythropoietin treatment in mood disorders?
Crossref DOI link: https://doi.org/10.1038/s41398-018-0270-z
Published Online: 2018-10-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Inkster, Becky
Zai, Gwyneth
Lewis, Gemma
Miskowiak, Kamilla W. http://orcid.org/0000-0003-2572-1384
Text and Data Mining valid from 2018-10-11
Version of Record valid from 2018-10-11
Article History
Received: 8 November 2017
Revised: 11 June 2018
Accepted: 14 July 2018
First Online: 11 October 2018
Conflict of interest
: The authors declare that they have no conflict of interest.